Subacute CNS demyelination after treatment with nivolumab for melanoma. Maurice C, Schneider R, Kiehl T-R, Bavi PP, Roehrl MHA, Mason WP, Hogg D Cancer Immunol Res. 2015 Sep 29. PMID: 26419960. Abstract CommentRecommendBookmarkWatch